SI Shoulder Innovations, Inc.

20.15USD-0.79%Mkt Cap: 421.58M USDP/E: 17.99
Insiders, last 90 daysNet sellers
Institutional holders20 on file

Key Statistics

Company
Market Cap421.58M USD
Enterprise Value—
Revenue (TTM)—
Gross Profit36.20M USD
Net Income (TTM)-40.36M USD
Revenue/Share—
Last Price20.15 USD
Fiscal Year End—
MR Quarter—
Employees—
CountryUS
SectorHealthcare
IndustryMedical Devices & Supplies
ISIN—
Valuation
P/E (Trailing)17.99
P/E (Forward)-13.08
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B3.56
EPS (TTM)—
EPS (Forward)—
52W Range
12.0065% of range24.59
52W High24.59 USD
52W Low12.00 USD
Profitability
Gross Margin76.51%
Oper. Margin—
EBITDA Margin—
Profit Margin-85.29%
ROE-28.67%
ROA-23.75%
ROIC-83.56%
ROCE-16.89%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-28.61M USD
CapEx (TTM)7.41M USD
FCF Margin—
FCF Yield—
Net Debt—
Net Debt/EBITDA—
Net Debt/FCF—
Balance Sheet
Debt/Equity0.11
Current Ratio—
Quick Ratio—
Book Value/Sh5.66 USD
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)27.00 USD
Upside (mean)+34.0%
Target Range25.00 USD – 28.00 USD
25.00+34.0% to mean28.00
# Analysts4
Ownership
Shares Out.20.92M
Float—
Insiders—
Institutions—
Technical
SMA 5019.10 (+5.5%)
SMA 20017.43 (+15.6%)
Beta—
S&P 52W Chg—
Avg Vol (30d)118.81K
Avg Vol (10d)167.71K
Technical Indicators
RSI (14)50.1
MACD0.3561
MACD Signal0.4706
MACD Hist.-0.1146
BB Upper22.06 USD
BB Middle20.40 USD
BB Lower18.75 USD
BB Width16.22%
ATR (14)1.079 USD
Vol Ratio (20d)1.24x

About Shoulder Innovations (NYSE: SI)

›

Shoulder Innovations (NYSE: SI) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Medical Devices & Supplies industry, part of the Healthcare sector.

The shares were at 20.15 USD on 20 November 2026, up 42.5% over 52 weeks. Its 52-week range is 12.00 USD to 24.59 USD: the price is 18.1% below the high and 67.9% above the low.

At a market capitalisation of 421.58M USD, it trades at 18.0 times trailing earnings. The median trailing P/E of its 19 largest Healthcare peers is 26.8, a discount of 33% for SI.

Shoulder Innovations reports return on equity of -28.7%.

Its Piotroski F-score is 4 out of 9, an average reading of its financial health. 4 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 27.00 USD is 34.0% above the current price. The next earnings report is expected on 9 March 2027.